![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/14/2898892/0/en/Bio-Path-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-European-Hematology-Association-Congress.html
https://www.globenewswire.com/news-release/2024/06/05/2894340/0/en/Bio-Path-Holdings-Announces-Closing-of-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/06/04/2892970/0/en/Bio-Path-Holdings-Announces-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/06/03/2892094/0/en/Bio-Path-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-American-Society-of-Clinical-Oncology-ASCO-Annual.html
https://www.globenewswire.com/news-release/2024/05/24/2887897/0/en/Bio-Path-Holdings-to-Present-Data-at-2024-European-Hematology-Association-Congress.html
https://www.globenewswire.com/news-release/2024/05/23/2887683/0/en/Bio-Path-Holdings-to-Present-Data-at-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/15/2882254/0/en/Bio-Path-Holdings-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/08/2877636/0/en/Bio-Path-Holdings-to-Announce-First-Quarter-2024-Financial-Results-on-May-15-2024.html
https://www.globenewswire.com/news-release/2024/04/19/2866293/0/en/Bio-Path-Holdings-Inc-Announces-Closing-of-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/04/18/2865747/0/en/Bio-Path-Holdings-Inc-Announces-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html